Life Sciences

Kemtai's markerless motion assessments and AI-guided exercises help life sciences companies differentiate clinical outcomes, qualify patients with objective movement biomarkers, and drive the adherence that unlocks the full impact of your therapy or device while generating real-world evidence at scale.

Enhance Your Clinical Value

Expand Market Share

Increase identification of eligible patients with scalable motion assessments

Differentiate Your Outcomes

Drive superior rehabilitation or exercise adherence through AI-guided movement with real-time feedback

Generate RWE

Generate insights for post-market surveillance, marketing, and regulatory submissions with real-world motion data

Optimize Intervention Timing

Use motion-based biomarkers to monitor disease progression and transition patients to the next line of therapy at the ideal clinical moment

Enhance Patient Loyalty and Safety

Provide a digital companion to support recovery and treatment adherence

Sample Use Cases

Key Capabilities

Which Kemtai website would you like to use?